Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH 2025 Congress
New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig)…
Global Panel Urges Rapid Reform of WHO and FCTC to Embrace Science, Transparency, and Consumer Voices
WASHINGTON, June 17, 2025 /PRNewswire/ -- The Taxpayers Protection Alliance (TPA) is…
U.S. Postal Service Releases Dog Bite National Rankings
National Dog Bite Awareness Campaign starts June 1 WASHINGTON, June 14, 2025…
New Policy Brief from the NDC Partnership Guides Countries Toward Tripling Renewable Energy
The NDC Partnership released a new policy brief today to support policymakers…
WASHINGTON FREEDOM ANNOUNCES MULTI-YEAR PARTNERSHIP WITH CLOVER
Clover joins Washington Freedom as Official Partner and Kit Sponsor to elevate…
Global Experts Warn WHO’s Anti-Harm Reduction Stance Undermines World No Tobacco Day
WASHINGTON, May 29, 2025 /PRNewswire/ -- A panel of global tobacco harm…
Clarifai Wins 2025 AI TechAward for Compute Orchestration
WASHINGTON, May 28, 2025 /PRNewswire/ -- Clarifai, a global leader in AI and…
AirHelp Launches First Unlimited, Free Flight-Tracking App for Passengers
Offers real-time flight tracking, disruption alerts, and built-in options for extra protectionPassengers…
A new passive income solution for 2025: Efficiently participate in Bitcoin and cryptocurrency mining with PairMiner
Washington, D.C., USA, May 22, 2025 (GLOBE NEWSWIRE) -- PAIRMiner, an advanced…
Global Alzheimers Platform Foundation ApplaudsFDA Authorization of the First Blood-Based Diagnostic Test for Assessing Alzheimers Disease
WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) -- The Global Alzheimer’s Platform Foundation®…